Home » Stocks » Midatech Pharma

Midatech Pharma PLC (MTP)

Stock Price: $2.00 USD 0.07 (3.63%)
Updated Aug 12, 2020 1:05 PM EDT - Market open

Stock Price Chart

Key Info

Market Cap 24.22M
Revenue (ttm) 878,697
Net Income (ttm) -13.15M
Shares Out 12.11M
EPS (ttm) -0.85
PE Ratio n/a
Forward PE n/a
Dividend n/a
Dividend Yield n/a

Stock Quote

Trading Day Aug 12, 2020
Last Price $2.00
Previous Close $1.93
Change ($) 0.07
Change (%) 3.63%
Day's Open 1.96
Day's Range 1.93 - 2.00
Day's Volume 80,359
52-Week Range 0.86 - 8.50

More Stats

Market Cap 24.22M
Enterprise Value 17.90M
Earnings Date (est) Sep 24, 2020
Ex-Dividend Date n/a
Shares Outstanding 12.11M
Float 6.33M
EPS (basic) n/a
EPS (diluted) -0.85
FCF / Share -4.65
Dividend n/a
Dividend Yield n/a
Earnings Yield n/a
FCF Yield n/a
Payout Ratio n/a
Shares Short 7,975
Short Ratio 0.15
Short % of Float n/a
Beta 1.66
PE Ratio n/a
Forward PE n/a
P/FCF Ratio n/a
PS Ratio 27.56
PB Ratio 1.00
Revenue 878,697
Operating Income -14.77M
Net Income -13.15M
Free Cash Flow -11.37M
Net Cash 6.32M
Net Cash / Share 0.52
Gross Margin 100.00%
Operating Margin -1,681.45%
Profit Margin -1,496.30%
FCF Margin -1,293.62%
ROA -27.56%
ROE -50.10%
ROIC n/a
Key stats in USD, based on trailing-twelve-month (ttm) numbers.

Analyst Summary

Analyst Ratings (0)

Buy 0
Overweight 0
Hold 0
Underweight 0
Sell 0

Analyst Consensus: n/a

Price Target

Current: $2.00
Target: 1,575
*Average 12-month USD price target from 1 stock analysts.

Financial Performance

Financial numbers in millions GBP.

Financial Overview

Revenue Growth-65.22%95.96%-25.25%-3.78%775.8%6.8%-
Gross Profit0.671.940.991.321.310.160.15
Operating Income-11.33-11.82-13.28-9.65-12.92-9.69-4.50
Net Income-10.09-15.03-16.06-20.16-10.10-8.82-4.08
Shares Outstanding12.2412.229.746.696.69--
Earnings Per Share-2.75-24.60-31.30-14.00-9.00-24.50-17.75
Operating Cash Flow-8.41-14.81-14.41-14.74-13.07-6.25-5.02
Capital Expenditures-0.31-0.22-0.71-1.35-0.92-1.03-0.05
Free Cash Flow-8.72-15.03-15.12-16.08-13.99-7.28-5.07
Cash & Equivalents10.932.3413.2017.6116.1830.332.39
Total Debt6.081.256.552.161.951.983.37
Net Cash / Debt4.851.096.6615.4514.2328.35-0.98
Book Value19.5616.9234.6845.7246.8941.990.76
Numbers in millions GBP, except per-share numbers.

Company Profile

Company Details

Full Name Midatech Pharma PLC
Country United Kingdom
Employees 65
CEO Stephen Anthony Stamp

Stock Information

Ticker Symbol MTP
Stock Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Unique Identifier NASDAQ: MTP


Midatech Pharma plc focuses on the research and development of oncology and rare disease products in the United Kingdom, rest of Europe, and internationally. The company is developing MTD201, a long acting dose of Octreotide for the treatment of acromegaly and neuroendocrine tumors; and MTX110, a direct delivery treatment for diffuse intrinsic pontine glioma. It also offers drug delivery platforms, such as Q-Sphera, a microencapsulation and polymer-depot sustained release drug delivery platform; MidaSolve, an oligosaccharide nanotechnology used to solubilize drugs so that they can be administered in liquid form directly and locally into tumors; and MidaCore, a gold nanoparticle used for targeting sites of disease by using chemotherapeutic agents or immunotherapeutic agents. Midatech Pharma plc was founded in 2000 and is headquartered in Cardiff, the United Kingdom.